Search

Search Constraints

You searched for: Author/Creator Huang, Yiran

Search Results

2. A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China. Issue 3 (15th March 2019)

3. Abiraterone acetate for metastatic castration‐resistant prostate cancer after docetaxel failure: A randomized, double‐blind, placebo‐controlled phase 3 bridging study. (15th February 2016)

6. Clinical outcomes of second‐line treatment following first‐line VEGFR‐TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti‐PD‐1 antibody. Issue 10 (7th August 2021)

9. Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first‐line therapy for Chinese patients with metastatic renal cell carcinoma. Issue 1 (8th August 2017)